UGENTi002-A-1

General

Cell Line

hPSCreg name UGENTi002-A-1
Cite as:
UGENTi002-A-1 (RRID:CVCL_D0MN)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 3rd July 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Ghent University (UGENT)
Owner Ghent University (UGENT)
Distributors
Derivation country Belgium

External Databases

BioSamples SAMEA113958745
Cellosaurus CVCL_D0MN
Wikidata Q123033697

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation.
Synonyms
  • Arrhythmogenic right ventricular cardiomyopathy
Genetic variants
Desmoplakin (target)
6p24.3
NG_008803.1(NM_001008844.3):c.817C>T
NP_001008844.1:Q273*
Heterozygous

External Databases (Donor)

BioSamples SAMEA113939457

Ethics

Also have a look at the ethics information for the parental line UGENTi002-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line UGENTi002-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
Yes
Methods used
RT-PCR

Vector free reprogramming

Type of used vector free reprogramming factor(s)
None

Other

Selection criteria for clones Flat morphology with rounded edges, desirable growth, expression of pluripotency markers
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
TrypLE
O2 Concentration 5 %
CO2 Concentration 5 %
Medium Essential 8™
Supplements
Penicillin/Streptomycin 1 %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
Score:
Marker Present Absent
mCpG
OCT4
Morphology pictures
morphology.tif
scalebar = 400µm
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
FOXA2
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
HAND1
Yes
brachyury
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • Arrhythmogenic right ventricular cardiomyopathy
Genetic modifications
Desmoplakin (target)
Isogenic modification
6p24.3
NG_008803.1(NM_001008844.3):c.817C>T
NP_001008844.1:Q273*
Heterozygous
Repaired